Literature DB >> 27082714

Early and extensive spinal white matter involvement in neuromyelitis optica.

Shotaro Hayashida1, Katsuhisa Masaki1, Tomomi Yonekawa1, Satoshi O Suzuki2, Akio Hiwatashi3, Takuya Matsushita1, Mitsuru Watanabe1, Ryo Yamasaki1, Toshihiko Suenaga4, Toru Iwaki2, Hiroyuki Murai5, Jun-Ichi Kira1.   

Abstract

OBJECTIVES: Studies of longitudinally extensive spinal cord lesions (LESCLs) in neuromyelitis optica (NMO) have focused on gray matter, where the relevant antigen, aquaporin-4 (AQP4), is abundant. Because spinal white matter pathology in NMO is not well characterized, we aimed to clarify spinal white matter pathology of LESCLs in NMO.
METHODS: We analyzed 50 spinal cord lesions from eleven autopsied NMO/NMO spectrum disorder (NMOSD) cases. We also evaluated LESCLs with three or fewer spinal cord attacks by 3-tesla MRI in 15 AQP4 antibody-positive NMO/NMOSD patients and in 15 AQP4 antibody-negative multiple sclerosis (MS) patients.
RESULTS: Pathological analysis revealed seven cases of AQP4 loss and four predominantly demyelinating cases. Forty-four lesions from AQP4 loss cases involved significantly more frequently posterior columns (PC) and lateral columns (LC) than anterior columns (AC) (59.1%, 63.6%, and 34.1%, respectively). The posterior horn (PH), central portion (CP), and anterior horn (AH) were similarly affected (38.6%, 36.4% and 31.8%, respectively). Isolated perivascular inflammatory lesions with selective loss of astrocyte endfoot proteins, AQP4 and connexin 43, were present only in white matter and were more frequent in PC and LC than in AC (22.7%, 29.5% and 2.3%, Pcorr  = 0.020, and Pcorr  = 0.004, respectively). MRI indicated LESCLs more frequently affected PC and LC than AC in anti-AQP4 antibody-seropositive NMO/NMOSD (86.7%, 60.0% and 20.0%, Pcorr  = 0.005, and Pcorr  = 0.043, respectively) and AQP4 antibody-seronegative MS patients (86.7%, 73.3% and 33.3%, Pcorr  = 0.063, and Pcorr  = 0.043, respectively). PH, CP and AH were involved in 93.3%, 86.7% and 73.3% of seropositive patients, respectively, and in 53.3%, 60.0% and 40.0% of seronegative patients, respectively.
CONCLUSIONS: NMO frequently and extensively affects spinal white matter in addition to central gray matter, especially in PC and LC, where isolated perivascular lesions with astrocyte endfoot protein loss may emerge. Spinal white matter involvement may also appear in early NMO, similar to cerebral white matter lesions.
© 2016 International Society of Neuropathology.

Entities:  

Keywords:  isolated perivascular lesion; longitudinally extensive spinal cord lesion (LESCL); multiple sclerosis; neuromyelitis optica; white matter

Mesh:

Substances:

Year:  2016        PMID: 27082714     DOI: 10.1111/bpa.12386

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  7 in total

1.  Clinical Characteristics and Outcomes of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder With Brainstem Lesions as Heralding Prodrome.

Authors:  Qiling Ji; Huiqing Dong; Hangil Lee; Zheng Liu; Yanna Tong; Kenneth Elkin; Yazeed Haddad; Xiaokun Geng; Yuchuan Ding
Journal:  Front Neurol       Date:  2022-05-09       Impact factor: 4.086

2.  Neuromyelitis Optica Spectrum Disorder Presenting with Pseudoathetosis.

Authors:  Hung Youl Seok; Seong Hwa Jang; Sooyeoun You
Journal:  J Clin Neurol       Date:  2018-01       Impact factor: 3.077

3.  Microstructural visual system changes in AQP4-antibody-seropositive NMOSD.

Authors:  Frederike C Oertel; Joseph Kuchling; Hanna Zimmermann; Claudia Chien; Felix Schmidt; Benjamin Knier; Judith Bellmann-Strobl; Thomas Korn; Michael Scheel; Alexander Klistorner; Klemens Ruprecht; Friedemann Paul; Alexander U Brandt
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-02-22

Review 4.  Mechanisms for lesion localization in neuromyelitis optica spectrum disorders.

Authors:  Monika Bradl; Markus Reindl; Hans Lassmann
Journal:  Curr Opin Neurol       Date:  2018-06       Impact factor: 5.710

5.  Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat.

Authors:  Sophie Hillebrand; Kathrin Schanda; Magdalini Nigritinou; Irina Tsymala; Denise Böhm; Patrick Peschl; Yoshiki Takai; Kazuo Fujihara; Ichiro Nakashima; Tatsuro Misu; Markus Reindl; Hans Lassmann; Monika Bradl
Journal:  Acta Neuropathol       Date:  2018-12-18       Impact factor: 17.088

Review 6.  Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases.

Authors:  Aigli G Vakrakou; Maria-Evgenia Brinia; Ioanna Svolaki; Theodore Argyrakos; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Front Neurol       Date:  2022-03-15       Impact factor: 4.003

Review 7.  Glial Fibrillary Acidic Protein in Blood as a Disease Biomarker of Neuromyelitis Optica Spectrum Disorders.

Authors:  Hyunjin Kim; Eun-Jae Lee; Young-Min Lim; Kwang-Kuk Kim
Journal:  Front Neurol       Date:  2022-03-17       Impact factor: 4.003

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.